Over 30% Covaxin takers suffered from health issues after one year, claims BHU study
New Delhi, May 16, 2024. Nearly one-third of the individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study conducted by a team of researchers at Banaras Hindu University. Nearly 50 percent of 926 study participants in the study complained of infections…